Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study-Reference-Cited by-同舟云学术

Methylation markers FAM19A4 and miR124 ‐2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study

Published:2020-10-21 Issue:2 Volume:148 Page:396-405
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bonde Jesper¹^ORCID,Floore Arno²,Ejegod Ditte¹,Vink Frederique J.³^ORCID,Hesselink Albertus²,Ven Peter M.⁴,Valenčak Anja Oštrbenk⁵,Pedersen Helle¹,Doorn Saskia²,Quint Wim G.⁶,Petry Karl Ulrich⁷^ORCID,Poljak Mario⁵,Stanczuk Grazyna⁸,Cuschieri Kate⁹^ORCID,Sanjosé Silvia¹⁰,Bleeker Maaike³,Berkhof Johannes⁴,Meijer Chris J. L. M.²³,Heideman Daniëlle A. M.³

Affiliation:

1. Molecular Pathology Laboratory, Department of Pathology Hvidovre Hospital Hvidovre Denmark

2. Self‐screen B.V Amsterdam The Netherlands

3. Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam Amsterdam The Netherlands

4. Department of Epidemiology and Biostatistics Amsterdam UMC, Vrije Universiteit Amsterdam Amsterdam The Netherlands

5. Institute of Microbiology and Immunology University of Ljubljana Ljubljana Slovenia

6. DDL Diagnostic Laboratory Rijswijk The Netherlands

7. Department of Gynaecology and Obstetrics Klinikum Wolfsburg Germany

8. Department of Obstetrics and Gynaecology Western Isles Hospital Scotland UK

9. HPV Research Group, Division of Pathology University of Edinburgh Scotland UK

10. Infections and Cancer Laboratory Catalan Institute of Oncology (ICO) Barcelona Spain

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33320

Reference35 articles.

1. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

2. ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

3. Age‐specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting;Leinonen M;J Natl Cancer Inst,2009

4. Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer

5. Human Papillomavirus and Papanicolaou Tests to Screen for Cervical Cancer

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging;Tumour Virus Research;2024-12

2. Assessing the Methylation Status of Two Potential Key Factors Involved in Cervical Oncogenesis;Reports;2024-08-18

3. Triage performance of PAX1m/JAM3m in opportunistic cervical cancer screening of non‒16/18 human papillomavirus-positive women: a multicenter prospective study in China;Clinical Epigenetics;2024-08-16

4. Methylation Analysis to Detect CIN3+ in High-Risk Human Papillomavirus-Positive Self-Samples From the Population-Based Cervical Cancer Screening Program;Modern Pathology;2024-08

5. Evaluation of silica spin‑column and magnetic bead formats for rapid DNA methylation analysis in clinical and point‑of‑care settings;Biomedical Reports;2024-06-10